A bill to facilitate the development of treatments for cancers, and for other purposes.

Hozzl · 2025-02-27T11:56:20Z

Explore the details of Senate Bill 755 A bill to facilitate the development of treatments for cancers, and for other purposes. currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on undefined. Stay informed on legislative developments.

2/27/2025, 11:56 AM

Summary of Bill S 755

Bill 119 s 755, also known as the "Cancer Treatment Facilitation Act," aims to streamline the process for developing new treatments for various types of cancer. The bill includes provisions to improve coordination between government agencies, research institutions, and pharmaceutical companies in order to expedite the research and development of innovative cancer therapies.

One key aspect of the bill is the establishment of a task force dedicated to identifying barriers to cancer treatment development and recommending solutions to overcome these obstacles. This task force will be composed of experts from the fields of oncology, pharmacology, and regulatory affairs, among others.

Additionally, the bill includes measures to increase funding for cancer research and clinical trials, with a focus on promoting collaboration between public and private entities. This funding will support the development of new drugs, therapies, and diagnostic tools for cancer patients. Overall, Bill 119 s 755 seeks to enhance the efficiency and effectiveness of the cancer treatment development process, ultimately aiming to improve outcomes for individuals battling cancer. The bill is a bipartisan effort to address the urgent need for innovative treatments in the fight against cancer.

Congressional Summary of S 755

Finn Sawyer Access to Cancer Testing Act

This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer.

Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.

Current Status of Bill S 755

Bill S 755 is currently in the status of Bill Introduced since February 26, 2025. Bill S 755 was introduced during Congress 119 and was introduced to the Senate on February 26, 2025. Bill S 755's most recent activity was Read twice and referred to the Committee on Finance. as of February 26, 2025